Erythropoietin Market Report

Global Erythropoietin Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 27, 2022
  • PAGES：150
  • REPORT CODE：GMM816891
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

    Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death. The classification of erythropoietin includes epoetin-alfa, epoetin-beta, darbepoetin-alfa and others. The proportion of epoetin-alfa in 2019 is about 58%. Erythropoietin is widely used for anemia and kidney disorders. The most proportion of Erythropoietin used in Kidney Disorders, and the market share in 2019 is 45%.

    Erythropoietin market report explains the definition, types, applications, major countries, and major players of the Erythropoietin market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Johnson & Johnson

    • Galenica

    • Amgen

    • Emcure

    • Kyowa Hakko Kirin

    • Roche

    • Biocon

    • LG Life Sciences

    • 3SBio

    By Type:

    • Epoetin-alfa

    • Epoetin-beta

    • Darbepoetin-alfa

    • Others

    By End-User:

    • Anemia

    • Kidney Disorders

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Erythropoietin Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Erythropoietin Outlook to 2028- Original Forecasts

    • 2.2 Erythropoietin Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Erythropoietin Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Erythropoietin Market- Recent Developments

    • 6.1 Erythropoietin Market News and Developments

    • 6.2 Erythropoietin Market Deals Landscape

    7 Erythropoietin Raw Materials and Cost Structure Analysis

    • 7.1 Erythropoietin Key Raw Materials

    • 7.2 Erythropoietin Price Trend of Key Raw Materials

    • 7.3 Erythropoietin Key Suppliers of Raw Materials

    • 7.4 Erythropoietin Market Concentration Rate of Raw Materials

    • 7.5 Erythropoietin Cost Structure Analysis

      • 7.5.1 Erythropoietin Raw Materials Analysis

      • 7.5.2 Erythropoietin Labor Cost Analysis

      • 7.5.3 Erythropoietin Manufacturing Expenses Analysis

    8 Global Erythropoietin Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Erythropoietin Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Erythropoietin Export by Region (Top 10 Countries) (2017-2028)

    9 Global Erythropoietin Market Outlook by Types and Applications to 2022

    • 9.1 Global Erythropoietin Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Epoetin-alfa Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Epoetin-beta Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Darbepoetin-alfa Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Erythropoietin Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Anemia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Kidney Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Erythropoietin Market Analysis and Outlook till 2022

    • 10.1 Global Erythropoietin Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Erythropoietin Consumption (2017-2022)

      • 10.2.2 Canada Erythropoietin Consumption (2017-2022)

      • 10.2.3 Mexico Erythropoietin Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Erythropoietin Consumption (2017-2022)

      • 10.3.2 UK Erythropoietin Consumption (2017-2022)

      • 10.3.3 Spain Erythropoietin Consumption (2017-2022)

      • 10.3.4 Belgium Erythropoietin Consumption (2017-2022)

      • 10.3.5 France Erythropoietin Consumption (2017-2022)

      • 10.3.6 Italy Erythropoietin Consumption (2017-2022)

      • 10.3.7 Denmark Erythropoietin Consumption (2017-2022)

      • 10.3.8 Finland Erythropoietin Consumption (2017-2022)

      • 10.3.9 Norway Erythropoietin Consumption (2017-2022)

      • 10.3.10 Sweden Erythropoietin Consumption (2017-2022)

      • 10.3.11 Poland Erythropoietin Consumption (2017-2022)

      • 10.3.12 Russia Erythropoietin Consumption (2017-2022)

      • 10.3.13 Turkey Erythropoietin Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Erythropoietin Consumption (2017-2022)

      • 10.4.2 Japan Erythropoietin Consumption (2017-2022)

      • 10.4.3 India Erythropoietin Consumption (2017-2022)

      • 10.4.4 South Korea Erythropoietin Consumption (2017-2022)

      • 10.4.5 Pakistan Erythropoietin Consumption (2017-2022)

      • 10.4.6 Bangladesh Erythropoietin Consumption (2017-2022)

      • 10.4.7 Indonesia Erythropoietin Consumption (2017-2022)

      • 10.4.8 Thailand Erythropoietin Consumption (2017-2022)

      • 10.4.9 Singapore Erythropoietin Consumption (2017-2022)

      • 10.4.10 Malaysia Erythropoietin Consumption (2017-2022)

      • 10.4.11 Philippines Erythropoietin Consumption (2017-2022)

      • 10.4.12 Vietnam Erythropoietin Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Erythropoietin Consumption (2017-2022)

      • 10.5.2 Colombia Erythropoietin Consumption (2017-2022)

      • 10.5.3 Chile Erythropoietin Consumption (2017-2022)

      • 10.5.4 Argentina Erythropoietin Consumption (2017-2022)

      • 10.5.5 Venezuela Erythropoietin Consumption (2017-2022)

      • 10.5.6 Peru Erythropoietin Consumption (2017-2022)

      • 10.5.7 Puerto Rico Erythropoietin Consumption (2017-2022)

      • 10.5.8 Ecuador Erythropoietin Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Erythropoietin Consumption (2017-2022)

      • 10.6.2 Kuwait Erythropoietin Consumption (2017-2022)

      • 10.6.3 Oman Erythropoietin Consumption (2017-2022)

      • 10.6.4 Qatar Erythropoietin Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Erythropoietin Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Erythropoietin Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Erythropoietin Consumption (2017-2022)

      • 10.7.2 South Africa Erythropoietin Consumption (2017-2022)

      • 10.7.3 Egypt Erythropoietin Consumption (2017-2022)

      • 10.7.4 Algeria Erythropoietin Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Erythropoietin Consumption (2017-2022)

      • 10.8.2 New Zealand Erythropoietin Consumption (2017-2022)

    11 Global Erythropoietin Competitive Analysis

    • 11.1 Johnson & Johnson

      • 11.1.1 Johnson & Johnson Company Details

      • 11.1.2 Johnson & Johnson Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Johnson & Johnson Erythropoietin Main Business and Markets Served

      • 11.1.4 Johnson & Johnson Erythropoietin Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Galenica

      • 11.2.1 Galenica Company Details

      • 11.2.2 Galenica Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Galenica Erythropoietin Main Business and Markets Served

      • 11.2.4 Galenica Erythropoietin Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Amgen

      • 11.3.1 Amgen Company Details

      • 11.3.2 Amgen Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Amgen Erythropoietin Main Business and Markets Served

      • 11.3.4 Amgen Erythropoietin Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Emcure

      • 11.4.1 Emcure Company Details

      • 11.4.2 Emcure Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Emcure Erythropoietin Main Business and Markets Served

      • 11.4.4 Emcure Erythropoietin Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Kyowa Hakko Kirin

      • 11.5.1 Kyowa Hakko Kirin Company Details

      • 11.5.2 Kyowa Hakko Kirin Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Kyowa Hakko Kirin Erythropoietin Main Business and Markets Served

      • 11.5.4 Kyowa Hakko Kirin Erythropoietin Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Roche

      • 11.6.1 Roche Company Details

      • 11.6.2 Roche Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Roche Erythropoietin Main Business and Markets Served

      • 11.6.4 Roche Erythropoietin Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Biocon

      • 11.7.1 Biocon Company Details

      • 11.7.2 Biocon Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Biocon Erythropoietin Main Business and Markets Served

      • 11.7.4 Biocon Erythropoietin Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 LG Life Sciences

      • 11.8.1 LG Life Sciences Company Details

      • 11.8.2 LG Life Sciences Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 LG Life Sciences Erythropoietin Main Business and Markets Served

      • 11.8.4 LG Life Sciences Erythropoietin Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 3SBio

      • 11.9.1 3SBio Company Details

      • 11.9.2 3SBio Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 3SBio Erythropoietin Main Business and Markets Served

      • 11.9.4 3SBio Erythropoietin Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Erythropoietin Market Outlook by Types and Applications to 2028

    • 12.1 Global Erythropoietin Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Epoetin-alfa Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Epoetin-beta Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Darbepoetin-alfa Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Erythropoietin Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Anemia Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Kidney Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Erythropoietin Market Analysis and Outlook to 2028

    • 13.1 Global Erythropoietin Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Erythropoietin Consumption Forecast (2022-2028)

      • 13.2.2 Canada Erythropoietin Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Erythropoietin Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.2 UK Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.3 Spain Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.5 France Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.6 Italy Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.8 Finland Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.9 Norway Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.11 Poland Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.12 Russia Erythropoietin Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Erythropoietin Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Erythropoietin Consumption Forecast (2022-2028)

      • 13.4.2 Japan Erythropoietin Consumption Forecast (2022-2028)

      • 13.4.3 India Erythropoietin Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Erythropoietin Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Erythropoietin Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Erythropoietin Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Erythropoietin Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Erythropoietin Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Erythropoietin Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Erythropoietin Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Erythropoietin Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Erythropoietin Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Erythropoietin Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Erythropoietin Consumption Forecast (2022-2028)

      • 13.5.3 Chile Erythropoietin Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Erythropoietin Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Erythropoietin Consumption Forecast (2022-2028)

      • 13.5.6 Peru Erythropoietin Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Erythropoietin Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Erythropoietin Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Erythropoietin Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Erythropoietin Consumption Forecast (2022-2028)

      • 13.6.3 Oman Erythropoietin Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Erythropoietin Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Erythropoietin Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Erythropoietin Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Erythropoietin Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Erythropoietin Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Erythropoietin Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Erythropoietin Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Erythropoietin Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Erythropoietin Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Erythropoietin

    • Figure of Erythropoietin Picture

    • Table Global Erythropoietin Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Erythropoietin Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Epoetin-alfa Consumption and Growth Rate (2017-2022)

    • Figure Global Epoetin-beta Consumption and Growth Rate (2017-2022)

    • Figure Global Darbepoetin-alfa Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Anemia Consumption and Growth Rate (2017-2022)

    • Figure Global Kidney Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Erythropoietin Consumption by Country (2017-2022)

    • Table North America Erythropoietin Consumption by Country (2017-2022)

    • Figure United States Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Canada Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Mexico Erythropoietin Consumption and Growth Rate (2017-2022)

    • Table Europe Erythropoietin Consumption by Country (2017-2022)

    • Figure Germany Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure UK Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Spain Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Belgium Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure France Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Italy Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Denmark Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Finland Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Norway Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Sweden Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Poland Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Russia Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Turkey Erythropoietin Consumption and Growth Rate (2017-2022)

    • Table APAC Erythropoietin Consumption by Country (2017-2022)

    • Figure China Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Japan Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure India Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure South Korea Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Thailand Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Singapore Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Philippines Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Erythropoietin Consumption and Growth Rate (2017-2022)

    • Table South America Erythropoietin Consumption by Country (2017-2022)

    • Figure Brazil Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Colombia Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Chile Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Argentina Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Peru Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Erythropoietin Consumption and Growth Rate (2017-2022)

    • Table GCC Erythropoietin Consumption by Country (2017-2022)

    • Figure Bahrain Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Oman Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Qatar Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Erythropoietin Consumption and Growth Rate (2017-2022)

    • Table Africa Erythropoietin Consumption by Country (2017-2022)

    • Figure Nigeria Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure South Africa Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Egypt Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Algeria Erythropoietin Consumption and Growth Rate (2017-2022)

    • Table Oceania Erythropoietin Consumption by Country (2017-2022)

    • Figure Australia Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Erythropoietin Consumption and Growth Rate (2017-2022)

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Erythropoietin Main Business and Markets Served

    • Table Johnson & Johnson Erythropoietin Product Portfolio

    • Table Galenica Company Details

    • Table Galenica Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galenica Erythropoietin Main Business and Markets Served

    • Table Galenica Erythropoietin Product Portfolio

    • Table Amgen Company Details

    • Table Amgen Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Erythropoietin Main Business and Markets Served

    • Table Amgen Erythropoietin Product Portfolio

    • Table Emcure Company Details

    • Table Emcure Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emcure Erythropoietin Main Business and Markets Served

    • Table Emcure Erythropoietin Product Portfolio

    • Table Kyowa Hakko Kirin Company Details

    • Table Kyowa Hakko Kirin Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyowa Hakko Kirin Erythropoietin Main Business and Markets Served

    • Table Kyowa Hakko Kirin Erythropoietin Product Portfolio

    • Table Roche Company Details

    • Table Roche Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Erythropoietin Main Business and Markets Served

    • Table Roche Erythropoietin Product Portfolio

    • Table Biocon Company Details

    • Table Biocon Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Erythropoietin Main Business and Markets Served

    • Table Biocon Erythropoietin Product Portfolio

    • Table LG Life Sciences Company Details

    • Table LG Life Sciences Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

    • Table LG Life Sciences Erythropoietin Main Business and Markets Served

    • Table LG Life Sciences Erythropoietin Product Portfolio

    • Table 3SBio Company Details

    • Table 3SBio Erythropoietin Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3SBio Erythropoietin Main Business and Markets Served

    • Table 3SBio Erythropoietin Product Portfolio

    • Figure Global Epoetin-alfa Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Epoetin-beta Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Darbepoetin-alfa Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kidney Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Erythropoietin Consumption Forecast by Country (2022-2028)

    • Table North America Erythropoietin Consumption Forecast by Country (2022-2028)

    • Figure United States Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Erythropoietin Consumption Forecast by Country (2022-2028)

    • Figure Germany Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Erythropoietin Consumption Forecast by Country (2022-2028)

    • Figure China Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Erythropoietin Consumption Forecast by Country (2022-2028)

    • Figure Brazil Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Erythropoietin Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Erythropoietin Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Erythropoietin Consumption Forecast by Country (2022-2028)

    • Figure Australia Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US